Pain Management Support Study for Patients With Advanced Cancer
Completed · Not applicable
Conditions studied: Advanced Cancer
In brief
Chronic pain is one of the most feared symptoms in people with cancer. Insufficient relief from pharmacological treatments and the fear of side effects are important reasons for the growing use of complementary pain management approaches in cancer care. On such approach is music therapy. Although several studies have demonstrated that music therapy interventions can reduce pain in people with cancer, few studies have examined the therapeutic mechanisms that explain how music therapy interventions lead to improved pain management. The purpose of this study is to examine whether an interactive music therapy intervention improves psychological and social factors that play an important role in chronic pain management in people with advanced cancer. The findings will contribute towards the optimization of music therapy for palliation of chronic pain in people with advanced cancer.
Key facts
- Study ID
- NCT03432247
- Run by
- Drexel University
- People needed
- 103
- Starts
- 2018-02-01
- Expected to finish
- 2021-12-31
- Last updated by the study team
- 2022-02-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- male or female outpatients with advanced cancer (Stage 3 \& 4; or relapse refractory patients for myeloma)
- diagnosed with locally advanced cancer that has extended to organs/soft tissue or is impinging on or eroding the bone; or bone metastases or soft tissue metastasis
- moderate to severe pain with an average intensity ≥4 on a 0-10 Numeric Rating Scale (NRS)
- experiencing pain for ≥ 3 months
- Karnofsky Performance score of ≥ 60 or the Eastern Cooperative Group Performance Status (ECOG) equivalent of ≤ 2 (i.e. requires occasional assistance, but is able to care for most of their personal needs)
You may not qualify if…
- expected survival ≤ 3 months
- primary central nervous system (CNS) tumor or CNS metastatic disease that impairs concentration, memory, balance or focus that would preclude ability to participate in a 60 minute, recurring activity and completion of self-report measures
- hematologic malignancies except for myeloma which causes significant bone pain
- ≤ 3 weeks post-operation from start of study
- active psychosis or dementia
- inability to speak or write English
- moderate to severe hearing impairment
- current smoking
- current alcohol dependence
Where it is running
- Hahnemann University Hospital — Philadelphia, Pennsylvania, United States
- Thomas Jefferson Sidney Kimmel Cancer Center — Philadelphia, Pennsylvania, United States
- Cancer Treatment Centers of America (CTCA) — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.